These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5786354)

  • 1. Studies on tetrahydroisoquinolines (THI) (VII): Effect of trimetoquinol on the cardiovascular system.
    Kiyomoto A; Sato M; Nagao T; Nakajima H
    Eur J Pharmacol; 1969 Mar; 5(4):303-12. PubMed ID: 5786354
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on tetradhydroisoquinolines (THI). II. Pharmacological action on the cardiovascular system.
    Sato M; Yamaguchi I; Kiyomoto A
    Jpn J Pharmacol; 1967 Jun; 17(2):153-63. PubMed ID: 5299980
    [No Abstract]   [Full Text] [Related]  

  • 3. Quinterenol, a new beta adrenergic stimulant.
    Scriabine A; Moore PF; Iorio LC; Goldman IM; McShane WK; Booher KD
    J Pharmacol Exp Ther; 1968 Jul; 162(1):60-9. PubMed ID: 4385348
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological study of pipratecol (JP 711) and of a pharmaceutical combination raubasine-JP 711].
    Laubie M; Le Douarec JC
    Arzneimittelforschung; 1969 Nov; 19(11):1820-6. PubMed ID: 4391788
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on tetrahydroisoquinolines (THI). 8. Pharmacological properties of metabolites of a new adrenergic -stimulant, trimetoquinol.
    Sato M; Nagao T; Murata S; Nakajima H; Kiyomoto A
    Jpn J Pharmacol; 1971 Jun; 21(3):401-8. PubMed ID: 4397669
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the action of isoproterenol and several related compounds on blood pressure, heart and bronchioles.
    Lands AM; Groblewski GE; Brown TG
    Arch Int Pharmacodyn Ther; 1966 May; 161(1):68-75. PubMed ID: 5941884
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on tetrahydroisoquinolines (THI). VI. Effects of trimetoquinol on tracheal and some other smooth muscles.
    Kiyomoto A; Iwasawa Y; Harigaya S
    Arzneimittelforschung; 1970 Jan; 20(1):46-52. PubMed ID: 4392500
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of the sympathomimetic action of cyclohexylamine and hexylamine: release of catecholamines from nerve endings.
    Wechsler AS; Epstein SE; Glick G
    J Pharmacol Exp Ther; 1969 Nov; 170(1):62-71. PubMed ID: 5351007
    [No Abstract]   [Full Text] [Related]  

  • 9. [Leukotrienes and the cardiovascular system].
    Sagach VF
    Patol Fiziol Eksp Ter; 1986; (1):84-9. PubMed ID: 3010220
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonequilibrium alpha adrenergic blockade and neuroleptic activity of N-ethoxycarbonyl-1,dihydroquinoline (BC-347).
    Martel RR
    J Pharmacol Exp Ther; 1969 Mar; 166(1):44-51. PubMed ID: 4304784
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of sympathomimetic effects on the cardiovascular system by 4-(2-isopropylamino-1-hydroxyethyl)methanesulfonanilide hydrochloride (MJ 1999).
    Aramendía P; Kaumann AJ
    J Pharmacol Exp Ther; 1967 Feb; 155(2):259-66. PubMed ID: 6025517
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the cardiovascular and anti-arrhythmic effects of methoxamine, isopropoxamine and butoxamine].
    Marmo E
    Minerva Cardioangiol; 1970 Jul; 18(7):426-48. PubMed ID: 5510026
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the pharmacology of 2,3-dioxybenzoic acid].
    Polukordas G; Repchite M; Skublitskene G
    Farmakol Toksikol; 1966; 29(5):594-7. PubMed ID: 5995071
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the effects of isoprenaline, orciprenaline, salbutamol and isoetharine on the cardiovascular system of anaesthetized dogs.
    Ekue JM; Shanks RG; Zaidi SA
    Br J Pharmacol; 1971 Sep; 43(1):23-31. PubMed ID: 5136459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosol administration of prostaglandins E 1 and E 2 and isoproterenol: studies on the cardiovascular system.
    Wendt RL; Baum T
    Eur J Pharmacol; 1972 Jan; 17(1):141-51. PubMed ID: 5016573
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiovascular effects of MY-5116 and MY-1250].
    Horii D; Hara Y; Hanazuka M; Nishi H
    Nihon Yakurigaku Zasshi; 1986 Apr; 87(4):417-26. PubMed ID: 3087848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro interactions of the new anorexic agent WY-5244 with cardiac and vascular tissue and with adrenergic mechanisms.
    Baum T; Gluckman MI
    J Pharmacol Exp Ther; 1967 Dec; 158(3):510-8. PubMed ID: 5624080
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of the pharmacology of salbutamol with that of isoprenaline, orciprenaline and trimetoquinol.
    Brittain RT
    Postgrad Med J; 1971 Mar; 47():Suppl:11-6. PubMed ID: 5572509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.